- Fillable
- Prefilled
Auto-Injectors Market size was valued at USD 45.4 billion in 2023 and is poised to grow at a significant CAGR of 17.6% from 2024-2030. An auto-injector is a medical device that is used to self-inject doses of drugs, typically life-saving drugs. Auto-injector keeps the needle tip covered before injecting and also have a safety mechanism to prevent accidental injection. auto-injector market is gaining importance these days to manage severe conditions like anaphylaxis, rheumatoid arthritis, multiple sclerosis, and others. Most of the auto-injectors are single-dose and spring-loaded syringes. The site of injection depends upon the drug-loaded.
Auto-injectors are easy to use and intended for self-administration by patients or any other caretaker or personnel at home. auto-injector market manufacturers are diversifying their product portfolio by introducing low-cost auto-injector products, incorporating advanced features into products, and with new product launches. For instance, Mylan N.V. introduced a generic version of EpiPen by reducing the price to half of its original product price. The initial pack of two was sold at US$ 600 until December 2016 and will be sold at US$ 300 from January 2017. Bayer AG introduced Betaconnect, an electronic auto-injector to treat relapsing-remitting multiple sclerosis in 2016. Companies are actively involved in collaborations and taking license agreements for auto-injector technology. In September 2016, Aptar Pharma (AptarGroup, Inc.) collaborated with Becton, Dickinson, and Company (BD) to develop an auto-injector using prefillable syringes from BD and Aptar Pharma's two-step auto-injector technology.
Global Auto Injectors Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
17.6%
Largest Market
North America
Fastest Growing Market
Asia Pacific
Auto-Injectors Market Dynamics
Global auto injectors market is mainly driven by increase in incidence of the life threatening conditions such as anaphylaxis, multiple sclerosis and other food allergies that need an emergency medication. In addition, advancements in auto injectors like introduction of jet injectors, growing home healthcare segment, and increase in demand for the self-injectors expected to bolster the market growth. Furthermore, new formulations, new drug delivery systems, and advancements in targeted drug delivery systems, favourable government policies are expected to boost the auto injectors market. Many biologics are administered as intravenously hence, many manufacturers are adopting auto injectors for the life-saving biologics. However, stringent regulatory requirements, recent product recalls, and presence of substitute products are hampering the global auto injectors market.
North-America Got Significant Share
Auto Injectors Market Regional Analysis
Geographically Global Auto Injectors Market segmented into following regions viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America expected to be a major market due to prevalence of anaphylaxis, favourable reimbursement policies and increase in healthcare expenditure. In Europe region, growth of auto injectors market is due to consumers shift from hospital based treatment to home care. Countries like China and India have huge growth potential due to increase in healthcare awareness, expenditure and regulatory initiatives to prevent needle stick injuries. However, various initiatives have been taken by World Health Organization (WHO) and regulatory agencies of the countries globally to create healthcare awareness and accelerate the adoption rate of auto-injectors in the Asia-Pacific region. The Middle East and Africa auto injectors market is expected to gain lucrative growth owing to increase in incidences of anaphylaxis and needle stick injuries due to poor healthcare practices in countries like South Africa.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Global Auto Injectors Market Segmentation
By Type
By Technology
- Automated
- Manual
By Application
- Anaphylaxis
- Rheumatoid Arthritis
- Multiple Sclerosis
- Others
By Distribution Channel
- Hospitals
- Retail Pharmacies
- Online Pharmacies
- Others
By Geography
- North America
- Asia Pacific
- Europe
- Latin America
- Middle East and Africa
Frequently Asked Questions
The auto-injectors market size was valued at USD 45.4 billion in 2023
The key segments covered in the auto-injectors market are technology, components, application, and end-users.
The Auto-injectors market key players Abbvie, Amgen, AstraZeneca, Bayer, Becton, Dickinson and Company, Biogen, Eli Lilly, Novartis, Teva Pharmaceuticals, Ypsomed
| 1.Executive Summary |
| 2.Global Auto-Injectors Market Introduction |
| 2.1.Global Auto-Injectors Market - Taxonomy |
| 2.2.Global Auto-Injectors Market - Definitions |
| 2.2.1.Type |
| 2.2.2.Technology |
| 2.2.3.Application |
| 2.2.4.Distribution Channel |
| 2.2.5.Region |
| 3.Global Auto-Injectors Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Auto-Injectors Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Auto-Injectors Market By Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Fillable |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Prefilled |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 6.Global Auto-Injectors Market By Technology, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Automated |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Manual |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 7.Global Auto-Injectors Market By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Anaphylaxis |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Rheumatoid Arthritis |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Multiple Sclerosis |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Others |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8.Global Auto-Injectors Market By Distribution Channel, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. Hospitals |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Retail Pharmacies |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Online Pharmacies |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Others |
| 8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 9.Global Auto-Injectors Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia Pacific (APAC) |
| 9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Middle East and Africa (MEA) |
| 9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Latin America |
| 9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 10.North America Auto-Injectors Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Fillable |
| 10.1.2.Prefilled |
| 10.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Automated |
| 10.2.2.Manual |
| 10.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Anaphylaxis |
| 10.3.2.Rheumatoid Arthritis |
| 10.3.3.Multiple Sclerosis |
| 10.3.4.Others |
| 10.4. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Hospitals |
| 10.4.2.Retail Pharmacies |
| 10.4.3.Online Pharmacies |
| 10.4.4.Others |
| 10.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.5.1.United States of America (USA) |
| 10.5.2.Canada |
| 11.Europe Auto-Injectors Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Fillable |
| 11.1.2.Prefilled |
| 11.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Automated |
| 11.2.2.Manual |
| 11.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Anaphylaxis |
| 11.3.2.Rheumatoid Arthritis |
| 11.3.3.Multiple Sclerosis |
| 11.3.4.Others |
| 11.4. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Hospitals |
| 11.4.2.Retail Pharmacies |
| 11.4.3.Online Pharmacies |
| 11.4.4.Others |
| 11.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.5.1.Germany |
| 11.5.2.France |
| 11.5.3.Italy |
| 11.5.4.United Kingdom (UK) |
| 11.5.5.Spain |
| 11.5.6.Rest of EU |
| 12.Asia Pacific (APAC) Auto-Injectors Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Fillable |
| 12.1.2.Prefilled |
| 12.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Automated |
| 12.2.2.Manual |
| 12.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Anaphylaxis |
| 12.3.2.Rheumatoid Arthritis |
| 12.3.3.Multiple Sclerosis |
| 12.3.4.Others |
| 12.4. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Hospitals |
| 12.4.2.Retail Pharmacies |
| 12.4.3.Online Pharmacies |
| 12.4.4.Others |
| 12.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.5.1.China |
| 12.5.2.India |
| 12.5.3.Australia and New Zealand (ANZ) |
| 12.5.4.Japan |
| 12.5.5.Rest of APAC |
| 13.Middle East and Africa (MEA) Auto-Injectors Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Fillable |
| 13.1.2.Prefilled |
| 13.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Automated |
| 13.2.2.Manual |
| 13.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Anaphylaxis |
| 13.3.2.Rheumatoid Arthritis |
| 13.3.3.Multiple Sclerosis |
| 13.3.4.Others |
| 13.4. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Hospitals |
| 13.4.2.Retail Pharmacies |
| 13.4.3.Online Pharmacies |
| 13.4.4.Others |
| 13.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.5.1.GCC Countries |
| 13.5.2.South Africa |
| 13.5.3.Rest of MEA |
| 14.Latin America Auto-Injectors Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 14.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.Fillable |
| 14.1.2.Prefilled |
| 14.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Automated |
| 14.2.2.Manual |
| 14.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Anaphylaxis |
| 14.3.2.Rheumatoid Arthritis |
| 14.3.3.Multiple Sclerosis |
| 14.3.4.Others |
| 14.4. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Hospitals |
| 14.4.2.Retail Pharmacies |
| 14.4.3.Online Pharmacies |
| 14.4.4.Others |
| 14.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.5.1.Brazil |
| 14.5.2.Mexico |
| 14.5.3.Rest of LA |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.Abbvie |
| 15.2.2.Amgen |
| 15.2.3.AstraZeneca |
| 15.2.4.Bayer |
| 15.2.5.Becton |
| 15.2.6.Dickinson and Company |
| 15.2.7.Biogen |
| 15.2.8.Eli Lilly |
| 15.2.9.Novartis |
| 15.2.10.Teva Pharmaceuticals |
| 15.2.11.Ypsomed |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
- Abbvie
- Amgen
- AstraZeneca
- Bayer
- Becton
- Dickinson and Company
- Biogen
- Eli Lilly
- Novartis
- Teva Pharmaceuticals
- Ypsomed